Table 2.
Rules of thumb for addressing practice effects in clinical trials
| Approach | Advantages | Pitfalls |
|---|---|---|
| Use of a control group | Necessary in placebo-controlled randomized clinical trial | Prone to confounding a practice effect with a treatment effect |
| Massed practice (multiple prebaseline testing) | Repeated testing during a prebaseline period may result in a task familiarity–based asymptote and can reduce interindividual and intraindividual variance due to subjects not fully understanding task demands. | Differential asymptotes between tests; possible ceiling effects; occlusion of treatment effects |
| Reliable change index | Is rigorous | Applicable to cases, not group means |
| Alternate forms | Clearly reduce practice effects | Forms may not be equivalent in difficulty level; influence of strategy formation |
| Practice-insensitive tests | Interpretation of improvement or lack of decline is straightforward | Relevance of cognitive operations; sensitivity to treatment |